First Trust Advisors
MGNX icon

First Trust Advisors’s MacroGenics MGNX Stock Holding History

First Trust Advisors’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-25,079
Closed -$221K – 2558
2022
Q1 		$221K Buy
25,079
+1,088
+5% +$12K ﹤0.01% 2447
2021
Q4 		$385K Buy
23,991
+4,858
+25% +$91.4K ﹤0.01% 2347
2021
Q3 		$401K Sell
19,133
-129,925
-87% -$3.13M ﹤0.01% 2329
2021
Q2 		$4M Buy
149,058
+125,300
+527% +$3.67M ﹤0.01% 1492
2021
Q1 		$757K Sell
23,758
-54,678
-70% -$1.33M ﹤0.01% 2072
2020
Q4 		$1.79M Buy
+78,436
New +$1.81M ﹤0.01% 1634
2017
Q1 		– Sell
-29,178
Closed -$596K – 2429
2016
Q4 		$596K Buy
+29,178
New +$734K ﹤0.01% 2046

Other funds holding MGNX

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

First Trust Advisors's MGNX Position: Q2 2022 in Review

First Trust Advisors sold out of MacroGenics (MGNX) in Q2 2022, closing a stake of 25,079 shares — an estimated $221K sold.

First Trust Advisors first reported a position in MGNX in Q4 2016 and held it in 7 quarters. The position peaked at $4M in Q2 2021. 133 funds tracked by Wall St. Rank hold MGNX as of Q2 2022.

  • First Trust Advisors reported no remaining MacroGenics position as of Q2 2022 after selling out during the quarter.
  • First Trust Advisors sold 25,079 MacroGenics shares in Q2 2022, an estimated $221K.
  • First Trust Advisors first reported a position in MacroGenics in Q4 2016 and held it in 7 quarters.
  • First Trust Advisors's MacroGenics position peaked at $4M in Q2 2021.
  • 133 funds tracked by Wall St. Rank held MacroGenics as of Q2 2022.

Based on First Trust Advisors's 13F filing for Q2 2022, filed 12 Aug 2022.